Press release
curasan AG: Dental Business Unit acquired as of June 1
Kleinostheim, Germany, June 6, 2013 – curasan AG, Germany, has acquired a large part of the “Oral Regenerative Medicine” division of Riemser Pharma GmbH, Germany, effective June 1, 2013.curasan AG now owns the marketing and distribution rights for the products covered by the contract and is assuming the sales structures, including the na-tional and international customer base.
As a result of this change, curasan has immediate access to the dental market in the USA, Canada, Australia, Latin America, Japan, Korea and China. Nu-merous Asian and Eastern European countries will be added upon receipt of the necessary regulatory approvals which are in process.
“The acquired sales organisation provides the major advantage of being able to introduce two new innovative products, namely Cerasorb® Foam and Cerasorb® Paste, in Europe immediately”, explained CEO Hans Dieter Rössler. “We now not only offer the top products for bone regeneration, but also the widest prod-uct line specifically designed to meet the needs of our users. Our goal is to double our sales in 2013 as compared to 2012, and to triple them in 2014.”
Background information about curasan AG:
curasan AG is one of the leading companies in the field of regenerative medicine and specialised on bone and tissue regeneration. The company has developed a future-oriented product pipeline in synthetic bone substitutes and bone regeneration material. Some of these various new developments already have been brought to market, and additional products will follow. These innovative biomaterials will be distributed in different submarkets by well-positioned contractual partners as well as by curasan’s own sales organi-sation. www.curasan.com
Press contact:
curasan AG
Andrea Weidner
Tel. +49 (0)6027 40 900-51
Fax +49 (0)6027 40 900-39
andrea.weidner@curasan.de
www.curasan.de
fr financial relations gmbh
Jörn Gleisner
Tel. +49 (0)6172 27159-20
Fax +49 (0)6172 27159-69
j.gleisner@financial-relations.de
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release curasan AG: Dental Business Unit acquired as of June 1 here
News-ID: 262710 • Views: …
More Releases from curasan AG
curasan AG now sells bone regeneration material in injectable form
Kleinostheim, 05.12.2012 – curasan AG, listed on the General Standard (ISIN: DE 000 549 453 8), has introduced its new bone regeneration material CERASORB® Ortho Paste to the German and European markets at the beginning of December.
CERASORB® Ortho Paste is comprised of fine granules of the proven, fully resorbable, synthetic material CERASORB® M Ortho suspended in a hyaluronic acid hydrogel-matrix. The paste-like product has the advantage that it is…
curasan AG commences operations in the European market with the appointment of a …
Kleinostheim, 15.02.2012 – curasan AG, listed in the General Standard (ISIN: DE 000 549 453 8), created a new post on 1st February 2012 in relation to the active expansion of its European sales network in the fields of Orthopaedics and trauma surgery. Mr. Lee McCann BSc Business Administration (North West University of Applied Science, London, U.K.), will be operating as the organisation’s International Sales Director for Orthobiologics with immediate…
curasan AG: Novel bone regeneration material approved for sale in Europe
Kleinostheim, Germany – curasan AG, which is listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received European approval for a novel synthetic bone regeneration material.
Osseolive® is a bioactive, poly-crystalline calcium-alkali-phosphate ceramic, which has a stimulating effect on bone formation as well as on bone mineralisation.
“With Osseolive® emerging from our well-stocked development pipeline, we now have an ideal extension to our tricalcium-phosphate…
curasan AG receives license for Osbone® Dental in the USA
Kleinostheim, Germany, 10th February 2011 - curasan AG, which is listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received FDA certification and, therefore, marketing authorization throughout the USA of the synthetic bone replacement material Osbone® Dental which already has been authorized in the EU as Osbone®.
Osbone® Dental is suitable for utilisation in general bone surgery, particularly in implantology and oral…
More Releases for Germany
Germany Agriculture Market, Germany Agriculture Industry, Germany Agriculture Da …
Agriculture is important sector for the Germany’s food security and also a provider of jobs. More than half of country’s national territory is used for farming. Approximately 1 million people currently work part-time or full-time in agricultural holdings. Key agricultural products include milk, cereals, potatoes, barley, cabbages, pork, beef, poultry, wheat, and sugar beets. In some regions fruits & vegetables, wine and other horticultural products play a significant role. Agricultural…
High Voltage System Market 2020: Top Key Players Are Bosch (Germany), Continenta …
High Voltage System Market Overview:
Research report on The High Voltage System Market by ‘Market Growth Insight’ covers deep analysis on key factors that directly influence the market growth including impact of COVID-19. The report is a thorough study of drivers, opportunities, restraints, challenges, and risks associated with the High Voltage System market to help the players plan their growth activities and strategies carefully, while considering these crucial factors. The High…
Product Engineering Services Market Outlook 2024 By Key Players: Accenture PLC(G …
Product Engineering Services Market reports report offers a comprehensive evaluation of the global market analysis (2019-2024). This 94 pages research study involves the extensive use of both primary interviews and secondary research data sources. The report consists of market share, size, CAGR, industry analysis, go to market strategy, SWOT analysis, sales, revenue, key players, information on products and application, competitive insights, value chain, and macroeconomic analysis etc.
The product engineering is…
2019 Autonomous Luxury Vehicle Market | By Leading Players: Daimler (Germany), B …
Autonomous Luxury Vehicle Market report covers the data which is helpful for key players, product scope, market overview, market opportunities, market risk, market driving force, technological advancement, distributors, traders, dealers, research findings. These data representations provide predictive data regarding the future estimations for convincing market growth.
Download PDF Sample of this Report @
https://www.reporthive.com/enquiry.php?id=1510050&req_type=smpl&utm_source=SN
Key Players including:
• Daimler (Germany)
• BMW (Germany)
• Tesla (US)
• Audi (Germany)
• Robert Bosch (Germany)
• Continental (Germany)
• Denso (Japan)
• Delphi (UK)
This 108 pages of report focuses on…
Global Contrast Sensor Market 2025 | BALLUFF(Germany), CONTRINEX(Swizerland), Di …
Researchmoz added Most up-to-date research on "Global Contrast Sensor Market Insights, Forecast to 2025" to its huge collection of research reports.
The Contrast Sensor market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the…
Laparoscopic Electrodes Market - Aesculap (Germany), Angiodynamics (USA), Bovie …
Global Laparoscopic Electrodes Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Laparoscopic Electrodes Market revenue and price, market share, market growth and gross margin by regions.
Top Manufacturers/Key Players:
Aesculap (Germany)
Angiodynamics (USA)
Bovie Medical (USA)
BOWA-electronic (Germany)
Erbe Elektromedizin GmbH (Germany)
Ethicon Endo Surgery (USA)
Gunter Bissinger Medizintechnik (Germany)
HEBUmedical (Germany)
Lagis Endosurgical (China Taiwan)
LaproSurge (UK)
Maxer Endoscopy (Germany)
Mediflex Surgical Products (USA)
Megadyne (Italy)
MetroMed Healthcare (China…
